Research Article
No access
Published Online: 8 September 2020

Disparities Research in Thyroid Cancer: Challenges and Strategies for Improvement

Publication: Thyroid
Volume 30, Issue Number 9


Until recently, thyroid cancer was one of the most rapidly increasing cancers in the United States. Disparities exist in many aspects of thyroid cancer care as a result of the multifactorial interplay of systemic, patient, and physician factors. To better understand the management of thyroid cancer in populations at risk for health disparities and subsequently implement changes that will lead to health equity for all patients with thyroid cancer, health services research with innovative approaches is necessary.

Get full access to this article

View all available purchase options and get full access to this article.


1. National Institute on Minority Health and Health Disparities. Health disparity populations. Available at (accessed January 1, 2020).
2. United States Census Bureau. Available at (accessed January 1, 2020).
3. The Williams Institute, UCLA School of Law. How many people are lesbian, gay, bisexual, and transgender? Available at (accessed January 1, 2020).
4. Shah SA, Adam MA, Thomas SM, Scheri RP, Stang MT, Sosa JA, Roman SA 2017 Racial disparities in differentiated thyroid cancer: have we bridged the gap? Thyroid 27:762–772.
5. Wenaas AE, Nagy CZ, Yiu Y, Xu L, Horter K, Zevallos JP 2015 Demographic and socioeconomic factors predictive of compliance with American Thyroid Association guidelines for the treatment for advanced papillary thyroid carcinoma. Head Neck 37:1776–1780.
6. Weeks KS, Kahl AR, Lynch CF, Charlton ME 2018 Racial/ethnic differences in thyroid cancer incidence in the United States, 2007–2014. Cancer 124:1483–1491.
7. Harari A, Li N, Yeh MW 2014 Racial and socioeconomic disparities in presentation and outcomes of well-differentiated thyroid cancer. J Clin Endocrinol Metab 99:133–141.
8. Sosa JA, Mehta PJ, Wang TS, Yeo HL, Roman SA 2007 Racial disparities in clinical and economic outcomes from thyroidectomy. Ann Surg 246:1083–1091.
9. Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R 1998 The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 228:320–330.
10. Haymart MR, Banerjee M, Stewart AK, Koenig RJ, Birkmeyer JD, Griggs JJ 2011 Use of radioactive iodine for thyroid cancer. JAMA 306:721–728.
11. Papaleontiou M, Reyes-Gastelum D, Gay BL, Ward KC, Hamilton AS, Hawley ST, Haymart MR 2019 Worry in thyroid cancer survivors with a favorable prognosis. Thyroid 29:1080–1088.
12. Chen DW, Reyes-Gastelum D, Wallner LP, Papaleontiou M, Hamilton AS, Ward KC, Hawley ST, Zikmund-Fisher BJ, Haymart MR 2019 Disparities in risk perception of thyroid cancer recurrence and death. Cancer 126:1512–1521.
13. National Institute of Health. Improving smoking cessation in socioeconomically disadvantaged populations via scalable interventions. Available at (accessed January 1, 2020).
14. Zevallos JP, Xu L, Yiu Y 2014 The impact of socioeconomic status on the use of adjuvant radioactive iodine for papillary thyroid cancer. Thyroid 24:758–763.
15. Ullmann TM, Gray KD, Limberg J, Stefanova D, Moore MD, Buicko J, Finnerty B, Zarnegar R, Fahey TJ, Beninato T 2019 Insurance status is associated with extent of treatment for patients with papillary thyroid carcinoma. Thyroid 29:1784–1791.
16. Moten AS, Zhao H, Intenzo CM, Willis AI 2019 Disparity in the use of adjuvant radioactive iodine ablation among high-risk papillary thyroid cancer patients. Eur J Surg Oncol 45:2090–2095.
17. Zahnd WE, James AS, Jenkins WD, Izadi SR, Fogleman AJ, Steward DE, Colditz GA, Brard L 2018 Rural-urban differences in cancer incidence and trends in the United States. Cancer Epidemiol Biomarkers Prev 27:1265–1274.
18. McDow AD, Zahnd WE, Angelos P, Mellinger JD, Ganai S 2020 Impact of rurality on national trends in thyroid cancer incidence and long-term survival. J Rural Health 36:326–333.
19. National Institute of Health. Plans for advancing LGBT health research. Available at (accessed January 1, 2020).
20. Griggs J, Maingi S, Blinder V, Denduluri N, Khorana AA, Norton L, Francisco M, Wollins DS, Rowland JH 2017 American Society of Clinical Oncology position statement: strategies for reducing cancer health disparities among sexual and gender minority populations. J Clin Oncol 35:2203–2208.
21. Gomez SL, Duffy C, Griggs JJ, John EM 2019 Surveillance of cancer among sexual and gender minority populations: Where are we and where do we need to go? Cancer 125:4360–4362.
22. Institute of Medicine Committee on Lesbian G, Bisexual, and Transgender Health Issues and Research Gaps and Opportunities 2011 The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding. National Academies Press, Washington.
23. National Institute of Health. Sexual and gender minority populations in NIH-supported research. Available at (accessed January 1, 2020).
24. Lubitz CC, Kong CY, McMahon PM, Daniels GH, Chen Y, Economopoulos KP, Gazelle GS, Weinstein MC 2014 Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer 120:1345–1352.
25. Barrows CE, Belle JM, Fleishman A, Lubitz CC, James BC 2020 Financial burden of thyroid cancer in the United States: An estimate of economic and psychological hardship among thyroid cancer survivors. Surgery 167:378–384.
26. White MG, Applewhite MK, Kaplan EL, Angelos P, Huo D, Grogan RH 2017 A tale of two cancers: traveling to treat pancreatic and thyroid cancer. J Am Coll Surg 225:125–136.
27. Santry HP, Wren SM 2012 The role of unconscious bias in surgical safety and outcomes. Surg Clin North Am 92:137–151.
28. Chapman EN, Kaatz A, Carnes M 2013 Physicians and implicit bias: how doctors may unwittingly perpetuate health care disparities. J Gen Intern Med 28:1504–1510.
29. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295:2164–2167.
30. Haymart MR, Banerjee M, Reyes-Gastelum D, Caoili E, Norton EC 2019 Thyroid ultrasound and the increase in diagnosis of low-risk thyroid cancer. J Clin Endocrinol Metab 104:785–792.
31. Esfandiari NH, Hughes DT, Reyes-Gastelum D, Ward KC, Hamilton AS, Haymart MR 2019 Factors associated with diagnosis and treatment of thyroid microcarcinomas. J Clin Endocrinol Metab 104:6060–6068.
32. Magreni A, Bann DV, Schubart JR, Goldenberg D 2015 The effects of race and ethnicity on thyroid cancer incidence. JAMA Otolaryngol Head Neck Surg 141:319–323.
33. Miller KD, Goding Sauer A, Ortiz AP, Fedewa SA, Pinheiro PS, Tortolero-Luna G, Martinez-Tyson D, Jemal A, Siegel RL 2018 Cancer statistics for hispanics/latinos, 2018. CA Cancer J Clin 68:425–445.
34. Kotwal A, Bleyer A, Brito JP 2019 Thyroid cancer incidence continues to rise but mortality remains stable in young, hispanic, and black populations in the United States. Endocr Pract 25:115–116.
35. Zagzag J, Kenigsberg A, Patel KN, Heller KS, Ogilvie JB 2017 Thyroid cancer is more likely to be detected incidentally on imaging in private hospital patients. J Surg Res 215:239–244.
36. American Cancer Society. Cancer health disparities research. Available at (accessed January 20, 2020).
37. Association of American Medical Colleges. Health equity grants and funding opportunities. Available at (accessed January 1, 2020).
38. American Cancer Society. Key statistics for thyroid cancer. Available at (accessed January 1, 2020).

Information & Authors


Published In

cover image Thyroid®
Volume 30Issue Number 9September 2020
Pages: 1231 - 1235
PubMed: 32340582


Published online: 8 September 2020
Published in print: September 2020
Published ahead of print: 21 May 2020
Published ahead of production: 28 April 2020


Request permissions for this article.




Debbie W. Chen
Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Megan R. Haymart [email protected]
Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.


Address correspondence to: Megan R. Haymart, MD, Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Building 16, Room 408E, Ann Arbor, MI 48109, USA [email protected]

Author Disclosure Statement

No competing financial interests exist.

Funding Information

This work is supported by the National Cancer Institute (NCI) grant no. R01 CA201198 to Principal Investigator (M.R.H). M.R.H. also receives funding from R01 HS024512 from the Agency for Healthcare Research and Quality (AHRQ). D.W.C. receives support from grant T32DK07245 from the National Institutes of Diabetes and Digestive and Kidney Diseases.

Metrics & Citations



Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options


View PDF/ePub

Full Text

View Full Text







Copy the content Link

Share on social media

Back to Top